In summary, published data suggest that A1M could inhibit both the oxidation of LDL and thereby the progression of atherosclerosis and counteract the damaging reactions of extracellular Hb-metabolites after IPH (Figure 7). This evidence concerns the gene GSTM1 and atherosclerosis.